Alessandro became CEO of Resalis in October 2022, bringing two decades of experience in the pharmaceutical industry. He has held leadership roles at major companies such as Merck, Pfizer, Shire, and Novartis, where he previously led the Immunology, Respiratory, and Allergy franchises in Italy. In addition to his work at Resalis, he is a Business Angel with Italian Angels for Growth, supporting oncology startups. Alessandro holds an MSc in Chemistry from the University of Pisa and a PhD in Chemistry from the University of Milan.